Telepatia, a startup that sells AI software to hospitals in Latin America, raised a $33m Series A led by Andreessen Horowitz, the venture firm announced on 17 June 2026.
Palantir chief technology officer Shyam Sankar, Rappi founder Simón Borrero and Nubank founder David Vélez also invested. Pulse 2.0 reported that existing investors A-Star, Abstract, Canary, Picus and SV Angel took part, and that the company has raised $42m in total.
No valuation was disclosed. The round came eight months after a $9m seed round in October 2025.
“We’re building an AI Doctor and our goal is to bring Latin America its first Nobel Prize in Medicine since 1984.”Nicolas Abad, Founder and CEO, Telepatia AI
What Telepatia does
Telepatia's platform combines AI note-taking during consultations, clinical decision support and what a16z calls AI healthcare employees, including AI doctors, nurses and auditors. According to LatamList, its assistant transcribes consultations in real time, reviews medical records, flags possible drug interactions and makes recommendations based on medical literature and clinical guidelines. a16z said the models are also trained on local hospital protocols.
The company was founded in 2025 by chief executive Nicolas Abad, according to LatamList. Pulse 2.0 reported that the name came from his late father's nickname; his father was a doctor who died at 58 of a preventable cause. Pulse 2.0 said the company moved from Stanford to São Paulo less than a year before the round, and that much of the team is engineers and doctors returning to Latin America from cities such as San Francisco, Boston and London.
Traction
Since its launch in July 2025, a16z said, the platform has been deployed in more than 25 hospital systems in Brazil, Colombia and Mexico and has reached 14 million patients. LatamList also listed Chile and Argentina among its markets. Named customers include Hospital Mater Dei in Brazil and Fundación Santa Fe de Bogotá in Colombia.
a16z said that protocol adherence at customer hospitals rose from 84% to 99% after deployment, that doctors saved 1.7 hours a day and that the software had caught 60,000 medical errors in real time. Telepatia told Pulse 2.0 that its tools catch one in three medical errors before they reach the patient. These figures are company and investor claims and have not been independently verified.
José Henrique Dias Salvador, chief executive of Mater Dei, told a16z that his hospital's physicians use the product eight hours a day.
What the money is for
Telepatia will use the funding to expand across Latin America and to enter other underserved healthcare markets, including India, Africa and Southeast Asia, according to LatamList.
Its earlier seed round of $9m was led by A-Star, with Canary, Abstract, Picus, SV Angel, Nido and angel investors taking part, LatamList reported in October 2025.
a16z partners Daisy Wolf, Gabriel Vasquez and Eva Steinman wrote the firm's announcement. They said Abad's stated goal is to win the first Nobel Prize in Medicine for a Latin American since 1984.
Company website: telepatia.ai